Concepedia

Drake M. Mellott

DM

Statistics

Publications

10

Citations

409

H-Index

10

Active since

2020

Affiliations

Texas A&M University(Current)

The University of Texas Medical Branch at Galveston

University of California San Diego

Utah State University

Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry

Drake M. Mellott is an author at Texas A&M University specializing in drug discovery, enzyme inhibition, and viral protease inhibition.

ORCID

Publications per year

2020–2022

10

Publications

10

A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells

Drake M. Mellott, Chien‐Te K. Tseng, Aleksandra Drelich et al. · ACS Chemical Biology · 2021 · 122 citations

, , +17

Bepridil is potent against SARS-CoV-2 in vitro

Erol C. Vatansever, Kai S. Yang, Aleksandra Drelich et al. · Proceedings of the National Academy of Sciences · 2021 · 112 citations · Full text

, , +14

Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases

Linfeng Li, Balachandra Chenna, Kai S. Yang et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

, , +17

Targeting the SARS-CoV-2 Main Protease to Repurpose Drugs for COVID-19

Erol C. Vatansever, Kai S. Yang, Kaci C. Kratch et al. · 2020 · 32 citations

, , +17

Bepridil is potent against SARS-CoV-2 In Vitro

Erol C. Vatansever, Kai S. Yang, Kaci C. Kratch et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 30 citations · Full text

, , +14

1–5 of 10